[144] Legend Biotech Corporation American SEC Filing

Rhea-AI Filing Summary

Legend Biotech Corporation (NASDAQ: LEGN) has filed a Form 144 indicating a proposed insider sale of American Depositary Shares (ADS). According to the notice, the reporting shareholder plans to sell 11,810 ADS through Fidelity Brokerage Services on or about 24 June 2025. At the reference market price used in the filing, the transaction is valued at roughly $408,600. The sale represents an immaterial 0.003 % of the company’s 367.3 million ADS outstanding, suggesting limited direct impact on the public float.

The securities to be sold stem from restricted stock that vested on 20 June 2025 as part of the filer’s compensation package. Form 144 data also disclose prior sales by the same individual—4,064 ADS on 25 March 2025 for $143,371 and 6,548 ADS on 1 May 2025 for $226,233. Cumulatively, the filer has disposed of 10,612 ADS (≈$369,604) in the past three months, and the new planned trade will bring three-month total dispositions to 22,422 ADS worth about $778,000.

The filing includes the standard representation that the seller is unaware of any undisclosed material adverse information. No details about the filer’s position, trading plan status, or reason for the sale are provided. While insider sales can raise governance questions, the small size relative to capitalization and the routine vesting-related nature of the shares suggest limited financial significance for shareholders.

Positive

• None.

Negative

• Continued insider selling: the same shareholder plans to sell 11,810 ADS after disposing of 10,612 ADS in the prior three months, which may weigh on investor sentiment despite being immaterial in size.

Insights

Securities Analyst

TL;DR: Routine Form 144 shows minor insider sale of 11.8k LEGN ADS; immaterial to float but signals continued personal profit-taking.

The proposed sale equals just 0.003 % of shares outstanding and follows two earlier trades totaling 10.6 k ADS. Combined, the seller will have liquidated roughly 22.4 k ADS for ≈$0.78 m within one quarter—still negligible versus LEGN’s multi-billion-dollar market cap. The shares were acquired via normal vesting, so tax- or diversification-driven selling is plausible. No negative operational data are disclosed. From a valuation standpoint, the event is non-material; however, persistent insider selling can influence sentiment, particularly if more executives follow suit. Overall, I classify the impact as neutral.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
American Depositary Shares	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	11810	408600.02	367298315	06/24/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
American Depositary Shares	06/20/2025	Restricted Stock Vesting	Issuer			11810	06/20/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Ying Huang 2101 Cottontail Lane Somerset NJ 08873	American Depositary Shares	03/25/2025	4064	143371.01
Ying Huang 2101 Cottontail Lane Somerset NJ 08873	American Depositary Shares	05/01/2025	6548	226233.40

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did Legend Biotech (LEGN) file?

A Form 144 notice indicating a proposed sale of 11,810 American Depositary Shares by an insider.

How many LEGN shares are being sold under this Form 144?

The filing covers 11,810 ADS with an estimated market value of $408,600.

When is the planned sale date for the LEGN shares?

The approximate sale date disclosed is 24 June 2025.

How significant is the sale relative to Legend Biotech’s total shares outstanding?

The 11,810 ADS represent only 0.003 % of the company’s 367.3 million ADS outstanding.

Has this insider sold LEGN shares recently?

Yes. The same filer sold 4,064 ADS on 25 Mar 2025 and 6,548 ADS on 1 May 2025, totaling 10,612 ADS.

Why were the LEGN shares acquired by the insider?

They were obtained through restricted stock vesting on 20 June 2025 as part of compensation.